eISSN: 2450-4459
ISSN: 2450-3517
Lekarz POZ
Current issue Archive Manuscripts accepted About the journal Supplements Abstracting and indexing Subscription Contact Instructions for authors
Editorial System
Submit your Manuscript
2/2019
vol. 5
 
Share:
Share:
abstract:
Review paper

Nonalcoholic fatty liver disease

Halina Cichoż-Lach
1

  1. Klinika Gastroenterologii z Pracownią Endoskopową, Uniwersytet Medyczny w Lublinie
Online publish date: 2019/07/09
View full text Get citation
 
Nonalcoholic fatty liver disease (NAFLD) is now the most frequent chronic liver disease and the most frequent cause of the abnormal activity of aminotransferases. It affects about 25% of the global adult population. In the article the current principles of diagnosis and treatment of NAFLD are presented. The questions frequently asked by family doctors are answered, and the responses are thoroughly discussed. The role of ursodeoxycholic acid (UDCA) in the therapy of nonalcoholic steatohepatitis (NASH) is emphasised.
keywords:

nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, diagnosis, treatment, ursodeoxycholic acid

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.